Refine
Year of publication
- 2022 (54) (remove)
Document Type
- Conference Proceeding (54) (remove)
Language
- English (54) (remove)
Has Fulltext
- yes (54)
Is part of the Bibliography
- no (54)
Keywords
- Open Science (6)
- DiGeo (1)
- Digital Higher Education (1)
- Digitality (1)
- Frankfurt Open Science Initiative (1)
- OER (1)
- Open Educational Resources (1)
- Public Private Partnership (1)
- Replication crisis (1)
Institute
In this contribution we report the status and plans of the open lattice initiative to generate and share new gauge ensembles using the stabilised Wilson fermion framework. The production strategy is presented in terms of a three stage plan alongside summaries of the data management as well as access policies. Current progress in completing the first stage of generating ensembles at four lattice spacings at the flavor symmetric point is given.
This work is focused on the anomalous skin effect in copper and how it affects the efficiency of copper-cavities in the temperature range 40-50 K. The quality factor Q of three coaxial cavities was measured over the temperature range from 10 K to room temperature in the experiment. The three coaxial cavities have the same structure, but different lengths, which correspond to resonant frequencies: around 100 MHz, 220 MHz and 340 MHz. Furthermore, the effects of copper-plating and additional baking in the vacuum oven on the quality factor Q are studied in the experiment. The motivation is to check the feasibility of an efficient, pulsed, ion linac, operated at cryogenic temperatures.
OPEN SCIENCE, VERSION 3.0: Breaking down barriers for equitable and efficient research communication
(2022)
Propranolol as a potentially novel treatment of arteriovenous malformations: from bench to bedside
(2022)
Background: Propranolol is a non-selective blocker of the β-adrenergic receptor and has been used for treatment of proliferative infantile hemangiomas. The vasoconstrictive and antiangiogenic effects of propranolol led us to explore its potential application for the treatment of AVMs.
Methods: AVM tissue was cultured after surgical resection in the presence of 100μM propranolol or solvent DMSO. After incubation for 72 hours, tissue was harvested for testing. The expression levels of SDF1α, CXCR4, VEGF and HIF-1 was measured by rt-PCR. Furthermore, data of patients in 2 vascular centres harboring AVM was retrospectively interrogated for a time period of 20 years. The database included information about hemorrhage, AVM size and antihypertensive medication. Descriptive analyses were performed, focusing on the risk of hemorrhage, size of the lesion at presentation and clinical follow-up in patients on β-blocker medication versus those who were not.
Results: Among 483 patients, 73 (15%) were under β-blocker-treatment. 48% AVMs presented with hemorrhage at diagnosis. Patients under β-blocker-treatment had a lower risk of hemorrhage at the time of diagnosis in a univariate analysis (p<0,0001;OR13). Patients under β-blocker-treatment showed a significant higher chance for a lower Spetzler-Martin-grade ≤III (p<0,0001;OR6,5) and a lower risk for the presence of an associated aneurysm (p<0,0001;OR3,6).
Multivariate analysis including Spetzler-Martin-Grading, young age ≤50, presence of associated aneurysm and β-blocker-treatment showed reduced risk for hemorrhage under β-blocker-treatment (p<0,01,OR0,2).
The expression of CXCR4 was suppressed by propranolol most likely through the HIF-1-pathways. The gene-expression of vasculogenesis factors was decreased in with propranolol incubated AVMs.
Conclusion: β-Blocker medication seems to be associated with a decreased risk of AVM-related hemorrhage and AVM-size at presentation or during follow-up. Propranolol inhibits SDF1α-induced vasculogenesis by suppressing the expression of CXCR4 most likely through the HIF-1-pathways. Therefore, SDF1α/CXCR4 axis plays an important role in the vasculogenesis and migration of inflammatory cells in AVM lesions.
Background: During the COVID-19 pandemic, decreased volumes of acute stroke admissions were reported. We aimed to examine whether subarachnoid hemorrhage (SAH) volumes demonstrated similar declines in our department. Furthermore, the impact of pandemic on disease progression should be analyzed.
Methods: We conducted a retrospective study in neurosurgical department of university hospital Frankfurt including patients with the diagnosis of aneurysmal SAH during the first year of COVID-pandemic. One year cumulative volume for SAH hospitalization procedures were compared to the one-year period before (03/2020–02/2021 versus 03/2019–02/2020) and the last 5 pre-COVID-pandemic years (2015-2020). All relevant patient characteristics concerning family history, disease history, clinical condition at admission, active/past COVID-infection, treatment management, complications and outcome were analyzed.
Results: There was a decline in SAH hospitalizations, with 84 admissions in the year immediately before and 56 admissions during the pandemic, without reaching a significance. No significant difference in analyzed patient characteristics including clinical condition at onset, treatment, complications and outcome, between 56 SAH patients admitted during COVID pandemic and treated patients in the last 5 years in pre-COVID period were found. Using a multivariable analysis, we detected young age (p<0.05;OR4,2) and no existence of early hydrocephalus (p<0.05;OR0,13) as important factors for a favorable outcome (mRS≤0-2) after aSAH during the COVID-pandemic. A past COVID-infection was detected in young patients suffering from aSAH (Age< 50years, p<0.05;OR10,5) with increased rate of cerebral vasospasm after SAH onset (p<0.05;OR26). Nevertheless, past COVID-infection did not reach a significance as a high risk factor for unfavorable outcome.
Conclusion: There was a relative decrease in the volume of SAH during the COVID-19 pandemic. Despite of extremely different conditions of hospitalization, there was no impairing significant effect on treatment and outcome of admitted SAH patients. A past COVID-infection seemed not to be a relevant limiting factor concerning favorable outcome.
Background: Following elective craniotomy patients routinely receive monitoring on ICU. However, the benefit of ICU monitoring in these patients is discussed controversially. Due to the current COVID-19 pandemic, there are further limitations of ICU capacities. This study aimed to compare this strategy with a standardized management of post-craniotomy patients on ICU.
Methods: Two postoperative strategies were compared in a matched-pair analysis: The first cohort included patients treated between May-August 2021 according to the “No ICU – unless” concept (NIU group), where patients were managed on the normal ward postoperatively. The second cohort contained patients routinely admitted to the ICU between February-April 2021 (control group). Outcome parameters contained complications, length of stay, duration to first postoperative mobilization, number of unplanned imaging, number/type of ICU interventions and pre- and postoperative mRS. Patient characteristics were analyzed using electronic medical records.
Results: The NIU group consisted of 96 patients, the control group of 75 patients. Complication rates were comparable in both cohorts (16% in NIU vs. 17% in control; p=0.123). Groups did not differ significantly in the number of imaging (10% in NIU vs. 13% in control; p=0.67), in the type of interventions on ICU (antihypertensive therapy 5% (NIU) vs. 6% (control); p=0.825) or in the time to first postoperative mobilization (average 1.1± 1.6 days vs. 0.9± 1.2 days; p=0.402). Length of hospital stay was shorter in the NIU group without reaching statistical significance (average 5.8 vs. 6.8 days; p=0.481). There was no significant change in the distribution of preoperative (p=0.960) and postoperative (p=0.425) mRS scores.
Conclusion: Postoperative ICU management does not reduce postoperative complications and has no effect on the surgical outcome of elective craniotomies. The majority of postoperative complications are detected after a 24-hour observation period. This approach may represent a potential strategy to prevent overutilization of ICU capacities while maintaining sufficient postoperative care for neurosurgical patients.
Background: A growing interest exists in using polymeric nanoparticles (NPs) especially functionalized with surface-active substances as carriers across the blood brain barrier (BBB) for potentially effective drugs in traumatic brain injury (TBI). However, the organ distribution of intravenous administrated biodegradable and non-biodegradable NPs coated with different surfactants, how much of the administrated dose reach the brain parenchyma in areas with intact and opened BBB after trauma, as well as whether they elicit an inflammatory response is still to be clarified.
Methods: The organ distribution, brain penetration and eventual inflammatory activation of polysorbate-80 (Tw80) and sodium-lauryl-sulfate (SDS) coated poly l-lactide (PLLA) and perfluorodecyl acrylate (PFDL) nanoparticles were evaluated after intravenous administration in rats prior and after undergoing controlled cortical impact (CCI).
Results: A significant highest NP uptake at 4 and 24 hs was observed in the liver and spleen, followed by the brain and kidney, with minimal concentrations in the lungs and heart for all NPs. After CCI, a significant increase of NP uptake at 4 hs and 24 hs was observed within the traumatized hemisphere, especially in the perilesional area, although NPs were still found in areas away from CCI and the contralateral hemisphere in similar concentrations as in non-CCI subject. NPs were localized in neurons, glial and endovascular cells. Immunohistochemical staining against GFAP, Iba1, TNFα and IL1β demonstrated no glial activation or neuroinflamatory changes.
Conclusions: Tw80 and SDS coated biodegradable (PLLA) and non-biodegradrable (PFDL) NPs reach the brain parenchyma in both areas of traumatized and undamaged brain with disrupted and intact BBB, even though a high amount of them are retained in the liver and the spleen. No inflammatory reaction is elicited by these NPs within 24 hs after application. These preliminary promising results postulate the effectiveness and safety of these NPs as drug-carriers for the treatment of TBI.
Background: The most frequent therapy of hydrocephalus is the implantation of ventriculoperitoneal shunts for diverting cerebrospinal fluid from the ventricles into the peritoneum. We compared two adjustable valves, the proGAV and proGAV 2.0, for complications which resulted in revision operations.
Methods: Four hundred patients who underwent primary shunt implantation between 2014 and 2020 were analyzed for overall revision rate, one-year revision rate, revision free survival and overall survival observing patient age group, gender, etiology of hydrocephalus, implantation site, prior diversion of cerebrospinal fluid and cause of revision.
Results: All data were available of all 400 patients (female/male 208/192). Overall, 99 patients underwent revision surgery after primary implantation. ProGAV valve was implanted in 283 patients, proGAV 2.0 in 117 patients. There was no significant difference between the two shunt valves concerning revision rate (p=0.8069), one-year revision rate (p=0.9077), revision free survival (p=0.6921) and overall survival (p=0.3232). Furthermore, regarding one-year revision rate, we observed no significant difference between the two shunt valves in pediatric patients (40.7% vs 27.6%; p=0.2247). Revision operation had to be performed more frequently in pediatric patients (46.6% vs 24.8%; p=0.0093) with a significant higher number of total revisions with proGAV than proGAV 2.0 (55.9% vs. 27.6%; p=0.0110) most likely due to longer follow up in the proGAV -group.
Conclusion: According to the target variables we analyzed, aside from lifetime revision rate in pediatric patients there is no significant difference between the two shunt valves. From our subjective point of view, implantation of the newer proGAV 2.0 valve is preferable due to higher adjustment comfort for both patients and physicians.
In this work we study the 3+1-dimensional Nambu-Jona-Lasinio (NJL) model in the mean field-approximation. We carry out calculations using five different regularization schemes (two continuum and three lattice regularization schemes) with particular focus on inhomogeneous phases and condensates. The regularization schemes lead to drastically different inhomogeneous regions. We provide evidence that inhomogeneous condensates appear for all regularization schemes almost exclusively at values of the chemical potential and with wave numbers, which are of the order of or even larger than the corresponding regulators. This can be interpreted as indication that inhomogeneous phases in the 3+1-dimensional NJL model are rather artifacts of the regularization and not a consequence of the NJL Lagrangian and its symmetries.
We refine our previous study of a udb¯b¯ tetraquark resonance with quantum numbers I(JP)=0(1−), which is based on antiheavy-antiheavy lattice QCD potentials, by including heavy quark spin effects via the mass difference of the B and the B∗ meson. This leads to a coupled channel Schrödinger equation, where the two channels correspond to BB and B∗B∗, respectively. We search for T matrix poles in the complex energy plane, but do not find any indication for the existence of a tetraquark resonance in this refined coupled channel approach. We also vary the antiheavy-antiheavy potentials as well as the b quark mass to further understand the dynamics of this four-quark system.
Effective three-dimensional Polyakov loop theories derived from QCD by strong coupling and hopping expansions are valid for heavy quarks and can also be applied to finite chemical potential μ, due to their considerably milder sign problem. We apply the Monte-Carlo method to the Nf=1,2 effective theories up to O(κ4) in the hopping parameter at μ=0 to determine the critical quark mass, at which the first-order deconfinement phase transition terminates. The critical end point obtained from the effective theory to order O(κ2) agrees well with 4-dimensional QCD simulations with a hopping expanded determinant by the WHOT-QCD collaboration. We also compare with full QCD simulations and thus obtain a measure for the validity of both the strong coupling and the hopping expansion in this regime.
The STAR experiment provides a perfect machinery for studying strange matter for more than two decades. Recently, we developed the express procedure, which allows online monitoring of the collected physics data. The high quality of express calibration and reconstruction provides a unique possibility to run the express production and observe almost in real time strange particles including mesons, hyperons, resonances and even hypernuclei.
The STAR Beam Energy Scan II program, including fixed target Au+Au collisions taken in 2018–2021, is particularly suited to study hypernuclei. Light hypernuclei are expected to be abundantly produced in low energy heavy-ion collisions. Measurements of hypernuclei production and their properties will provide information on the hyperon-nucleon interactions, which are essential ingredients for understanding nuclear matter equation of state at high net-baryon densities, such as inside neutron stars.
With the heavy fragment trigger introduced for the 2021 data taking, we were able to run the express production at the STAR High Level Trigger farm. The collected data were suffcient to observe the decay process of Λ5He →4Hepπ− with more than 11σ significance, measure binding energy as a function of hypernuclei mass, and study hypernuclei decay properties with the Dalitz plot technique.
We study the high temperature transition in pure SU(3) gauge theory and in full QCD with 3D-convolutional neural networks trained as parts of either unsupervised or semi-supervised learning problems. Pure gauge configurations are obtained with the MILC public code and full QCD are from simulations of Nf=2+1+1 Wilson fermions at maximal twist. We discuss the capability of different approaches to identify different phases using as input the configurations of Polyakov loops. To better expose fluctuations, a standardized version of Polyakov loops is also considered.
We present SU(3) lattice Yang-Mills data for hybrid static potentials from five ensembles with different small lattice spacings and the corresponding parametrizations for quark-antiquark separations 0.08fm≤r≤1.12fm. We remove lattice discretization errors at tree level of perturbation theory and partly at order a2 as well as the a-dependent self energy. In particular the tree-level improvement of static potentials is discussed in detail and two methods are compared. The resulting parametrizations are expected to represent continuum limit results for hybrid static potentials within statistical errors.
Gravitational-wave cosmology with dark sirens: state of the art and perspectives for 3G detectors
(2022)
A joint fit of the mass and redshift distributions of the population of Binary Black Holes detected with Gravitational-Wave observations can be used to obtain constraints on the Hubble parameter and on deviations from General Relativity in the propagation of Gravitational Waves. We first present applications of this technique to the latest catalog of Gravitational-Wave events, focusing on the comparison of different parametrizations for the source-frame mass distribution of Black Hole Binaries. We find that models with more than one feature are favourite by the data, as suggested by population studies, even when varying the cosmology. Then, we discuss perspectives for the use of this technique with third generation Gravitational-Wave detectors, exploiting the recently developed Fisher information matrix Python code GWFAST.
Study of I = 0 bottomonium bound states and resonances based on lattice QCD static potentials
(2022)
We investigate I=0 bottomonium bound states and resonances in S, P, D and F waves using lattice QCD static-static-light-light potentials. We consider five coupled channels, one confined quarkonium and four open B(∗)B¯(∗) and B(∗)sB¯(∗)s meson-meson channels and use the Born-Oppenheimer approximation and the emergent wave method to compute poles of the T matrix. We discuss results for masses and decay widths and compare them to existing experimental results. Moreover, we determine the quarkonium and meson-meson composition of these states to clarify, whether they are ordinary quarkonium or should rather be interpreted as tetraquarks.